171 related articles for article (PubMed ID: 35151243)
1. Inhibition of SRSF3 Alleviates Proliferation and Migration of Gastric Cancer Cells by Regulating the PI3K/AKT/mTOR Signalling Pathway.
Xie J; Sun Y; Xu Q
Folia Biol (Praha); 2021; 67(3):102-107. PubMed ID: 35151243
[TBL] [Abstract][Full Text] [Related]
2. SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.
Zhang L; Li J; Zhang L
Contrast Media Mol Imaging; 2022; 2022():8497078. PubMed ID: 36237584
[TBL] [Abstract][Full Text] [Related]
3. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway.
Wang RY; Chen XW; Zhang WW; Jiang F; Liu MQ; Shen XB
Mol Med Rep; 2020 Feb; 21(2):842-850. PubMed ID: 31974627
[TBL] [Abstract][Full Text] [Related]
4. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
5. CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway.
Gao LZ; Wang JQ; Chen JL; Zhang XL; Zhang MM; Wang SL; Zhao C
Appl Biochem Biotechnol; 2023 Nov; 195(11):6913-6926. PubMed ID: 36951936
[TBL] [Abstract][Full Text] [Related]
6. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
9.
Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
[TBL] [Abstract][Full Text] [Related]
10. SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
Qiu P; Li X; Gong M; Wen P; Wen J; Xu L; Wang G
Can J Gastroenterol Hepatol; 2023; 2023():2021515. PubMed ID: 36967718
[TBL] [Abstract][Full Text] [Related]
11. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
12. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
13. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
[TBL] [Abstract][Full Text] [Related]
14. KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway.
Wang T; Chen S; Wang Z; Li S; Fei X; Wang T; Zhang M
J Cell Mol Med; 2024 Jan; 28(1):e18020. PubMed ID: 37909722
[TBL] [Abstract][Full Text] [Related]
15. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway.
Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J
Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754
[TBL] [Abstract][Full Text] [Related]
16. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
17. The Sigma-2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K-AKT-mTOR Signalling Pathway in Renal Cancer.
Zhan B; Zhang Z; Piao C; Dong X; Du Y; Kong C; Jiang Y
J Cell Mol Med; 2021 Dec; 25(24):11244-11256. PubMed ID: 34783163
[TBL] [Abstract][Full Text] [Related]
18. PGAM5 promotes tumorigenesis of gastric cancer cells through PI3K/AKT pathway.
Meng L; Hu P; Xu A
Pathol Res Pract; 2023 Apr; 244():154405. PubMed ID: 36889176
[TBL] [Abstract][Full Text] [Related]
19. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling.
Wang J; Feng W; Dong Y; Mao X; Guo F; Luo F
Oncol Rep; 2018 Dec; 40(6):3654-3662. PubMed ID: 30272336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
